Suchergebnisse - "Senicapoc"

PubPharm (6)

1

The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson's disease

enthalten in: Journal of neuroinflammation | 2019

von Lu, J. | Dou, F. | Yu, Z.

2

The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson’s disease

enthalten in: Journal of neuroinflammation | 2019

von Lu, J. | Dou, F. | Yu, Z.

3

The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson’s disease

enthalten in: Journal of neuroinflammation | 2019

von Lu, J. | Dou, F. | Yu, Z.

4

The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson’s disease

in: Journal of Neuroinflammation | 2019

von Jia Lu | Fangfang Dou | Zhihua Yu

5

Inhibition of the potassium channel KCa3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury

enthalten in: European journal of pharmacology | 2017

von Staal, R. | Khayrullina, T. | Zhang, H. | +14

6

Senicapoc : Repurposing a Drug to Target Microglia KCa3.1 in Stroke

enthalten in: Neurochemical research | 2017

von Staal, R. | Weinstein, J. | Nattini, M. | +3

1
[1]